Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: Comparison with sporadic colorectal cancer

Journal of Pathology

Volumn 208, Issue 3, 2006, Pages 381-387

  Michael Robinson, J M ^a   Pandeya, N ^b   Walsh, M D ^b   Biemer Huttmann, A E ^c   Eri, R D ^a   Buttenshaw, R L ^a   Lincoln, D ^b   Clouston, A D ^c   Jaas, J R ^d   Radford Smith, Graham L ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Aminosalicylates; Apoptosis; Colorectal cancer; Granzyme B; Microsatellite instability; Tumour infiltrating lymphocytes; Ulcerative colitis

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; GRANZYME B; PROTEIN ANTIBODY;

AGED; APOPTOSIS; ARTICLE; CELL KILLING; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; ULCERATIVE COLITIS;

AGED; ANTIGENS, CD2; ANTIGENS, CD8; APOPTOSIS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; GRANZYMES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SERINE ENDOPEPTIDASES;

EID: 32344438276     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1895     Document Type: Article

References (43)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-535.
2. Ekbom A. Risk factors and distinguishing features of cancer in IBD. Inflamm Bowel Dis 1998;4:235-243.
3. Ribeiro MB, Greenstein AJ, Sachar DB, Barth J, Balasubramanian S, Harpaz N, et al. Colorectal adenocarcinoma in Crohn's disease. Ann Surg 1996;223:186-193.
4. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228-1233.
5. Munkholm P. The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003;18(suppl 2):1-5.
6. Lindberg BU, Broome U, Persson B. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Dis Colon Rectum 2001;44:77-85.
7. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-459.
8. Eaden JA. Review article: colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther 2004;20(suppl 4):24-30.
9. Hamilton SR. Colorectal carcinoma in patients with Crohn's disease. Gastroenterology 1985;89:398-407.
10. Mayer R, Wong WD, Rothenberger DA, Goldberg SM, Madoff RD. Colorectal cancer in inflammatory bowel disease: a continuing problem. Dis Colon Rectum 1999;42:343-347.
11. Connell WR, Talbot IC, Harpaz N, Britto N, Wilkinson KH, Kamm MA, et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994;35:1419-1428.
12. Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-1620.
13. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369-378.
14. Yin J, Harpaz N, Tong Y, Huang Y, Laurin J, Greenwald BD, et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993;104:1633-1639.
15. Ullman TA, Loftus EV Jr, Kakar S, Burgart LJ, Sandborn WJ, Tremaine WJ. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 2002;97:922-927.
16. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990;99:416-420.
17. Aust DE, Terdiman JP, Willenbucher RF, Chang CG, Molinaro-Clark A, Baretton GB, et al. The APC/β-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer 2002;94:1421-1427.
18. Willenbucher RF, Aust DE, Chang CG, Zelman SJ, Ferrell LD, Moore DH II, et al. Genomic instability is an early event during the progression pathway of ulcerative colitis-related neoplasia. Am J Pathol 1999;154:1825-1830.
19. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002;32:280-284.
20. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998;58:1713-1718.
21. Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, Schoch E, et al. Characterization of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999;52:455-460.
22. Michael-Robinson JM, Biemer-Hnttmann A-E, Purdie DM, Walsh MD, Simms LA, Biden KG, et al. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 2001;48:360-366.
23. Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 1999;154:1805-1813.
24. Kern SE, Redston M, Seymour AB, Caldas C, Powell SM, Kornacki S, et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 1994;107:420-428.
25. Suzuki H, Harpaz N, Tarmin L, Yin J, Jiang HY, Bell JD, et al. Microsatellite instability in ulcerative colitis-associated colorectal dysplasia and cancers. Cancer Res 1994;54:4841-4844.
26. Cawkwell L, Sutherland F, Murgatroyd H, Jarvis P, Gray S, Cross D, et al. Defective hMSH2/hMSH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut 2000;46:367-369.
27. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-968.
28. Jass JR, Do K-A, Simms LA, Iino H, Wynter C, Pillay SP, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998;42:673-679.
29. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-3502.
30. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257.
31. Leers MPG, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, et al. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 1998;187:567-572.
32. Ishitsuka T, Kashiwagi H, Konishi F. Microsatellite instability in inflamed and neoplastic epithelium in ulcerative colitis. J Clin Pathol 2001;54:526-532.
33. Cravo ML, Albuquerque CM, Salazar de Sousa L, Gloria LM, Chaves P, Dias Pereira A, et al. Microsatellite instability in non neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation. Am J Gastroenterol 1998;93:2060-2064.
34. Fleisher AS, Esteller M, Harpaz N, Leytin A, Rashid A, Xu Y, et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res 2000;60:4864-4868.
35. Jass JR, Sobin LH. Histological typing of intestinal tumours. In World Health Organization International Histological Classification of Tumours, 2nd edn. Springer-Verlag: Berlin, 1989; 32-33.
36. Radford-Smith GL. The role of the appendix and appendectomy in patients with IBD. IBD Monitor 2003;4:120-128.
37. Yang SK, Jung HY, Kang GH, Kim YM, Myung SJ, Shim KN, et al. Appendiceal orifice inflammation as a skip lesion in ulcerative colitis: an analysis in relation to medical therapy and disease extent. Gastrointest Endosc 1999;49:743-747.
38. Armstrong CP, Ahsan Z, Hinchley G, Prothero DL, Brodribb AJ. Appendicectomy and carcinoma of the caecum. Br J Surg 1989;76:1049-1053.
39. Friedman GD, Fireman BH. Appendectomy, appendicitis, and large bowel cancer. Cancer Res 1990;50:7549-7551.
40. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, et al. Microsatellite instability in non neoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996;56:1237-1240.
41. Mulder WMC, Bloemena E, Stukart MJ, Kummer JA, Wagstaff J, Scheper RJ. T cell receptor-ζ and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma. Gut 1997;40:113-119.
42. Jung S, Fehr S, Harder-d'Heureuse J, Wiedenmann B, Dignass AU. Corticosteroids impair intestinal epithelial wound repair mechanisms in vitro. Scand J Gastroenterol 2001;36:963-970.
43. Goel A, Chang DK, Ricciardiello L, Gasche C, Boland CR. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin Cancer Res 2003;9:383-390.